Rheumatoid Arthritis
Conditions
Interventions
psoriatic arthritis:None
systemic lupus erythematosus:None
gouty arthritis:None
connective tissue disease:None
Sponsors
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with RA meet the classification criteria for rheumatoid arthritis set by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) in 2009. Patients with gouty arthritis included in the study meet the 2015 ACR/EULAR classification criteria. Patients with ankylosing spondylitis included in the study meet the revised New York criteria established by the American College of Rheumatology in 1984. Patients with psoriatic arthritis included in the study meet the ACR classification criteria from 2006, and patients with a score =3 are diagnosed with psoriatic arthritis. Patients with systemic lupus erythematosus included in the study meet the 1997 classification criteria of the American College of Rheumatology. Patients with connective tissue diseases included in the study meet the 1982 classification criteria of the American College of Rheumatology. Patients with osteoarthritis included in the study meet the 1986 classification criteria of the American College of Rheumatology. Voluntary signing of an informed consent form.
Exclusion criteria
Exclusion criteria: 1. The patient is in the acute stage of acute infection or recurrent infectious disease at the time of screening 2. The patient is in a state of liver and kidney insufficiency and cardiac insufficiency at the time of screening 3. The patient suffers from severe, progressive, uncontrolled cardiovascular, cerebrovascular, liver, kidney, lung, gastrointestinal, hematopoietic, endocrine, nervous system and other diseases, as well as other conditions that the patient is not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease Activity Score 28-Joint Count with Erythrocyte Sedimentation Rate;Simplified Disease Activity Index;Clinical Disease Activity Index;Rheumatoid Factor;Anti-Citrullinated Protein Antibody;Visual Analog Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver and kidney function;Erythrocyte Sedimentation Rate;C-reactive protein; | — |
Countries
China
Contacts
Public ContactHe Dongyi
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed